Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6717
Gene Symbol: SRI
SRI
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker BEFREE We tested whether the <sup>-</sup>SCN analog selenocyanate (<sup>-</sup>SeCN) shares these properties against several clinical CF bacterial isolates. 31740228

2020

Entrez Id: 6917
Gene Symbol: TCEA1
TCEA1
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 GeneticVariation BEFREE Phase III slope (SIII), SIII standardized by exhaled tidal volume (SIII/TV) and capnographic index (SIII/SII)×100 (KPIv) were different among the three groups assessed, with highest values for CF. 30529075

2020

Entrez Id: 8431
Gene Symbol: NR0B2
NR0B2
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 AlteredExpression BEFREE Among the most strongly down-regulated genes are the FXR targets Fgf15 and Nr0b2, the PPARα target Pdk4, and the PXR target Ces2a, whereas expression of the CF modifier gene Slc6a14 was strongly increased. 31251978

2020

Entrez Id: 6857
Gene Symbol: SYT1
SYT1
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 AlteredExpression BEFREE Infection with Prevotella nigrescens induces TLR2 signalling and low levels of p65 mediated inflammation in Cystic Fibrosis bronchial epithelial cells. 31607634

2019

Entrez Id: 6779
Gene Symbol: STATH
STATH
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 GeneticVariation BEFREE Considering the negative screening for rare genetic variants in ADIPOQ and STATH genes, it may be concluded that these genes are not associated with phenotypic modulation of CF in our population. 31606405

2019

Entrez Id: 2006
Gene Symbol: ELN
ELN
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker BEFREE The impact of POE phenolic-rich fraction on the virulence attributes of CF-associated <i>Staphylococcus aureus</i> (<i>S. aureus</i>) clinical strains has been assessed, including pathogen adhesion, biofilm formation on native and protein-conditioned surfaces (mucin, elastin), mature biofilm eradication, staphylococcal protein A expression, α-toxin release, and <i>S. a.</i> adhesion to A549 cells. 30909529

2019

Entrez Id: 29108
Gene Symbol: PYCARD
PYCARD
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 AlteredExpression BEFREE We identify an enhanced proinflammatory signature, as evidenced by increased levels of IL-18, IL-1β, caspase-1 activity and ASC-speck release in monocytes, epithelia and serum with CF-associated mutations; these differences were reversed by pretreatment with NLRP3 inflammasome inhibitors and notably, inhibition of amiloride-sensitive sodium (Na<sup>+</sup>) channels. 31532390

2019

Entrez Id: 50616
Gene Symbol: IL22
IL22
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker BEFREE Consequently, we suspect an acquired deficiency of the IL-22 pathway in the lungs of CF patients due to IL-22 cleavage by the surrounding neutrophil serine-proteases. 30377053

2019

Entrez Id: 6611
Gene Symbol: SMS
SMS
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker BEFREE SMS reminders sent to CF patients might improve influenza vaccine uptake. 30192711

2019

Entrez Id: 5315
Gene Symbol: PKM
PKM
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker BEFREE The lack of effective antiinflammatory therapies for people with CF (PWCF) represents a significant challenge.<b>Objectives:</b> To identify altered immunometabolism in the CF neutrophil and investigate the feasibility of specific inhibition of the NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) inflammasome as a CF antiinflammatory strategy <i>in vivo</i>.<b>Methods:</b> Key markers of increased aerobic glycolysis, known as a Warburg effect, including cytosolic PKM2 (pyruvate kinase M2), phosphorylated PKM2, succinate, HIF-1α (hypoxia-inducible factor-1α), lactate, and the IL-1β precursor pro-IL-1β, as well as caspase-1 activity and processing of pro-IL-1β to IL-1β by the NLRP3 inflammasome, were measured in neutrophils from blood and airway secretions from healthy control subjects (<i>n</i> = 12), PWCF (<i>n</i> = 16), and PWCF after double-lung transplantation (<i>n</i> = 6). 31454256

2019

Entrez Id: 112935892
Gene Symbol: LINC02605
LINC02605
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 AlteredExpression BEFREE Time course analyses after 1 year +/- 6 months showed increased IL-7 serum levels (time point 1:9.26 pg/ml, IQR 6.94-13.12 time point 2:10.86 pg/ml, IQR 9.14-14.76, p = .016) that correlated negatively with decreased FEV1<sub>%pred</sub> during CF disease course. 30389600

2019

Entrez Id: 2695
Gene Symbol: GIP
GIP
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 AlteredExpression BEFREE During oral glucose tolerance testing, non-CF ferrets had responsive insulin, glucagon like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) levels and maintained normal glucose levels, whereas CF ferrets had insufficient responses and became hyperglycemic. 30738804

2019

Entrez Id: 10657
Gene Symbol: KHDRBS1
KHDRBS1
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker BEFREE Taken together, these results suggest that G3BP1, p62 and USP10 could be therapeutic targets for ubiquitinated protein aggregation disorders, including PD and CF. 31501480

2019

Entrez Id: 1476
Gene Symbol: CSTB
CSTB
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker BEFREE MBIR constructed ULD-CT is an effective imaging modality for CF surveillance, with potential applications in other disease settings. 31090256

2019

Entrez Id: 3064
Gene Symbol: HTT
HTT
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker BEFREE ADCYAP1 and huntingtin were identified as predicted unique regulators of altered metabolic pathways in CF compared to non-CF. 30477895

2019

Entrez Id: 54795
Gene Symbol: TRPM4
TRPM4
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 AlteredExpression BEFREE Differentiated normal bronchial epithelial (NHBE) cells and tracheal cells from patients with cystic fibrosis (CFT1-LC3) expressed only TRPM4 and all three isoforms of NCXs. 30482841

2019

Entrez Id: 3574
Gene Symbol: IL7
IL7
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 AlteredExpression BEFREE Time course analyses after 1 year +/- 6 months showed increased IL-7 serum levels (time point 1:9.26 pg/ml, IQR 6.94-13.12 time point 2:10.86 pg/ml, IQR 9.14-14.76, p = .016) that correlated negatively with decreased FEV1<sub>%pred</sub> during CF disease course. 30389600

2019

Entrez Id: 7306
Gene Symbol: TYRP1
TYRP1
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 AlteredExpression BEFREE The Transient Receptor Potential (TRP) protein superfamily is a group of cation channels expressed in various cell types and involved in respiratory diseases such as cystic fibrosis (CF), the genetic disease caused by CF Transmembrane conductance Regulator (CFTR) mutations. 31176886

2019

Entrez Id: 6530
Gene Symbol: SLC6A2
SLC6A2
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker BEFREE Dysregulation of NET production and/or degradation can exert pathogenic effects, contributing to the pathogenesis of various diseases, including cystic fibrosis, autoimmune diseases and inflammatory conditions. 31114589

2019

Entrez Id: 5066
Gene Symbol: PAM
PAM
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker BEFREE Study 2 examined the association between PAM-13 and objectively measured nebuliser adherence in 57 adults with CF. 31234848

2019

Entrez Id: 9140
Gene Symbol: ATG12
ATG12
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 GeneticVariation BEFREE Using reduced representation bisulfite sequencing (RRBS) to determine DNA methylation profile, we found that the promoter regions of Atg12 in CF macrophages are significantly more methylated than in the wild-type (WT) immune cells, accompanied by low protein expression. 30737168

2019

Entrez Id: 79813
Gene Symbol: EHMT1
EHMT1
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker BEFREE GLP-1 agonists are a candidate treatment in CF-related diabetes. 30259623

2019

Entrez Id: 1088
Gene Symbol: CEACAM8
CEACAM8
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker BEFREE CSFs were tested on non CF neutrophils to investigate their effects on reactive oxygen species (ROS) production, degranulation (CD66b, elastase, lactoferrin, MMP-9), and chemotaxis. 31506515

2019

Entrez Id: 100125288
Gene Symbol: ZGLP1
ZGLP1
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker BEFREE GLP-1 agonists are a candidate treatment in CF-related diabetes. 30259623

2019

Entrez Id: 64689
Gene Symbol: GORASP1
GORASP1
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 AlteredExpression BEFREE Infection with Prevotella nigrescens induces TLR2 signalling and low levels of p65 mediated inflammation in Cystic Fibrosis bronchial epithelial cells. 31607634

2019